Back to CRVS
DCF Advisers, LLC CRVS Position History
Corvus Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$7.4M
Q3 2026
Peak value
$9.5M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $5.6M |
| Q1 2026 | $9.3M |
| Q2 2026 | $9.5M |
| Q3 2026 | $7.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $7.4M | 641.5K | — | — |
| Q2 2026 | $9.5M | 637.5K | — | — |
| Q1 2026 | $9.3M | 637.5K | — | — |
| Q4 2025 | $5.6M | 729.0K | — | — |